Company Filing History:
1 out of 597 
1 out of 1 Years Active: 2019
Title: Ger Stienen: Innovator in Heart Failure Diagnosis and Treatment
Introduction
Ger Stienen is a notable inventor based in Abcoude, Netherlands. He has made significant contributions to the field of cardiology, particularly in the diagnosis and treatment of heart failure. His innovative work has the potential to improve patient outcomes and advance medical research.
Latest Patents
Ger Stienen holds a patent for "Methods of diagnosing and treating heart failure." This invention focuses on novel phosphorylation sites in cardiac Troponin I that are associated with the onset of heart failure. The identified phosphorylation sites, including serine 5, tyrosine 26, threonine 51, serine 166, threonine 181, and serine 199, can serve as biomarkers for several purposes. These include identifying individuals at risk for developing heart failure, treating those with elevated biomarker levels, and monitoring therapy in at-risk patients. Additionally, the patent describes antibodies, reagents, and kits designed for implementing the methods outlined in the invention.
Career Highlights
Throughout his career, Ger Stienen has worked with esteemed organizations such as Cedars-Sinai Medical Center and Vu-vumc IP Management B.V. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Ger Stienen has collaborated with notable professionals, including Pingbo Zhang and Jennifer E Van Eyk. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Ger Stienen's innovative contributions to the diagnosis and treatment of heart failure exemplify the importance of research and development in the medical field. His patent and collaborations highlight the potential for advancements that can significantly benefit patients and healthcare providers alike.